Fluorescence Enhanced Stereotactic Surgery (FESS)
Recruiting
Observational Study
High Grade Glioma
High Grade Glioma (III or IV)
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Histopathological diagnosis is essential for gliomas, but stereotactic biopsy carries significant risks and can fail to provide diagnostic tissue. This study aims to develop and validate an advanced fiber optic system integrated into a standard Nashold biopsy needle. This system combines 5-ALA fluorescence, Raman spectroscopy, and ultrasound imaging to provide real-time feedback on tumor tissue an…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient aged 18 years or older
* Patients able to provide the informed consentPresumptive diagnosis of high grade glioma
* Patient whose surgery require the use of 5-ALA as standard of treatment
Exclusion Criteria:
* Patients who are not suitable for surgery
* Patients unabl…
Contacts
No contact information available.